Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (3): 169-175.
Previous Articles Next Articles
GONG Li-xiong1, WANG Chang-zhi1, CHEN Chao1, YANG Yue2, CHEN Jian-gang2, GUO Hui1, MA Xue-jiao1, LIU Chao1
Received:
2017-11-23
Revised:
2018-05-04
Online:
2018-03-20
Published:
2018-05-04
CLC Number:
GONG Li-xiong, WANG Chang-zhi, CHEN Chao, YANG Yue, CHEN Jian-gang, GUO Hui, MA Xue-jiao, LIU Chao. Study on Risk Classification and Management of ADR Monitoring Varieties in Pharmaceutical Enterprises in Henan Province[J]. Chinese Journal of Pharmacovigilance, 2018, 15(3): 169-175.
[1] 国家食品药品监督管理总局.国家药品不良反应监测年度报告2016年[EB/OL]. (2017-04-28)[2017-07-07]. http://www.sda.gov.cn/WS01/CL0844/172167.html. [2] 韩若斯, 杨悦. 假劣药品的风险来源与监管措施研究[J]. 中国药事, 2015, 29(7):682-686. [3] 许维成. 注射剂的质量风险管理与控制[D]. 山东大学, 2012. [4] 宋敏, 黄泰康. 口服固体制剂生产的风险监管策略研究[J]. 中国药房, 2013, 24(1):4-6. [5] 王蒙, 郭晓晶, 冯红云,等. 基于药品不良反应监测系统的假冒伪劣医疗产品检测方法[J]. 中国药物警戒, 2017, 14(8):489-492. [6] 冯红云, 侯永芳, 吴桂芝,等. 药品不良事件聚集性信号预警系统的建立和运行[J]. 中国药物警戒, 2012, 9(12):745-748. [7] 陈建军, 于志强, 朱昀. 数据可视化技术及其应用[J]. 红外与激光工程, 2001, 30(5):339-342. [8] 任经天, 王胜锋, 侯永芳,等. 常用药品不良反应信号检测方法比较研究[J]. 中国药物警戒, 2011, 8(6):356-359. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||